April Reg Top Ten Hits: Speculation About Trilogue Outcomes - Good And Bad - Top Readers’ Lists
This article was originally published in Clinica
Executive Summary
The trilogue talks on the future EU Medical Device and IVD Regulations are now in the home stretch and two more discussions are due on May 11 and 25. With the final vote expected to go ahead on June 17, Clinica’s top ten stories of last month reflect industry’s desire to gain a better understanding of the likely outcome of these trilogues.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.